Gemcitabine, fludarabine and melphalan for reduced-intensity conditioning and allogeneic stem cell transplantation for relapsed and refractory Hodgkin lymphoma

Forty patients with Hodgkin lymphoma underwent an allogeneic stem cell transplant with the gemcitabine-fludarabine-melphalan reduced-intensity conditioning regimen. The median age was 31 years (range 20–63). Thirty-one (77%) had undergone a prior autologous stem cell transplant, and the median time...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biol Blood Marrow Transplant
Hlavní autoři: Anderlini, Paolo, Saliba, Rima M., Ledesma, Celina, Plair, Tamera, Alousi, Amin M., Hosing, Chitra M., Khouri, Issa F., Nieto, Yago, Popat, Uday R., Shpall, Elizabeth J, Fanale, Michelle A., Hagemeister, Frederick B., Oki, Yasuhiro, Neelapu, Saatva, Romaguera, Jorge E., Younes, Anas, Champlin, Richard E.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5193224/
https://ncbi.nlm.nih.gov/pubmed/27064056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.03.028
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky